Influenza B Articles & Analysis
7 articles found
Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...
Biobot has always believed in the transformative power of wastewater data for public health. We started by making this important data available during the COVID-19 pandemic to fill critical data gaps nationally in an easily digestible way. Our data not only helped the public, but empowered public health departments and researchers to utilize its potential. But as the field of wastewater ...
The recent COVID-19 pandemic again highlighted the urgent need for broad-spectrum antivirals, both for therapeutic use in acute viral infection and for pandemic preparedness in general. The targeting of host cell factors hijacked by viruses during their replication cycle presents one possible strategy for development of broad-spectrum antivirals. By inhibiting the Raf/MEK/ERK signaling pathway, ...
Introduction Oseltamivir phosphate is a white or almost white crystalline powder with the chemical name ethyl(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-cyclohex-1-ene-1-carboxylate phosphate. It is an influenza viral neuraminidase inhibitor used in the prevention and treatment of influenza. Application in the treatment of influenza Introduction of influenza Influenza, also called flu or ...
In many developing countries throughout the world, infant and child mortality rates are disturbingly high, and acute respiratory infections— in particular pneumonia—are a leading cause of death. As a result, preventing pneumonia is a priority, and the World Health Organization (WHO) and other healthcare institutions are studying a number of vaccines designed to protect against the ...
Abstract Both influenza A and B viruses cause outbreaks of seasonal influenza resulting in significant morbidity and mortality. There are two antigenically distinct lineages of influenza B virus, Yamagata lineage (YL) and Victoria lineage (VL). Since both B lineages have been co-circulating for years, more than 70% of influenza vaccines currently manufactured are quadrivalent consisting of ...
David Wahlberg, Wisconsin State Journal October 18, 2018 With flu season approaching, health officials say people should get flu shots by the end of October, yet acknowledge that the annual vaccine generally works less than 60 percent of the time. The Madison company FluGen is part of a renewed national effort to improve the odds by developing a universal flu vaccine, which would protect ...